Search research articles
Contact Us
Filters
Showing results (261-270 of 320) with videos related to
Page
of 32
Sort By:
The Journal of Infectious Diseases
|
May 1, 1984
Dose response of cold-adapted, reassortant influenza A/California/10/78 virus (H1N1) in adult volunteers
B R Murphy, M L Clements, H P Madore, et al.
Reviews of Infectious Diseases
|
May 1, 1989
Prospects for development of a rotavirus vaccine against rotavirus diarrhea in infants and young children
A Z Kapikian, J Flores, Y Hoshino, et al.
Blood
|
October 9, 2010
Distinct molecular mechanisms responsible for bortezomib-induced death of therapy-resistant versus -sensitive B-NHL cells
Scott H Olejniczak, Jennifer Blickwedehl, Alan Belicha-Villanueva, et al.
The Journal of Infectious Diseases
|
October 17, 2019
A Novel Antiparasitic Compound Kills Ring-Stage Plasmodium falciparum and Retains Activity Against Artemisinin-Resistant Parasites
Rebecca L Clements, Vincent Streva, Peter Dumoulin, et al.
Infection and Immunity
|
May 1, 1982
Evaluation of a phenotypic revertant of the A/Alaska/77-ts-1A2 reassortant virus in hamsters and in seronegative adult volunteers: further evidence that the temperature-sensitive phenotype is responsible for attenuation of ts-1A2 reassortant viruses
M D Tolpin, M L Clements, M M Levine, et al.
Journal of Clinical Gastroenterology
|
December 1, 1985
Percutaneous biopsy of pancreatic masses
V M Phillips, T Hersh, B C Erwin, et al.
Journal of Neuro-Oncology
|
September 22, 2018
KX2-361: a novel orally bioavailable small molecule dual Src/tubulin inhibitor that provides long term survival in a murine model of glioblastoma
Michael J Ciesielski, Yahao Bu, Stephan A Munich, et al.
The Journal of Infectious Diseases
|
March 1, 1993
Safety and immunogenicity of a recombinant protein influenza A vaccine in adult human volunteers and protective efficacy against wild-type H1N1 virus challenge
L F Fries, S B Dillon, J E Hildreth, et al.
The Journal of Infectious Diseases
|
August 11, 1992
Vaccination of vaccinia-naive adults with human immunodeficiency virus type 1 gp160 recombinant vaccinia virus in a blinded, controlled, randomized clinical trial. The AIDS Vaccine Clinical Trials Network
B S Graham, R B Belshe, M L Clements, et al.
International Immunology
|
June 6, 2000
In vitro and in vivo macrophage function can occur independently of SLP-76
P S Myung, J L Clements, D W White, et al.
Page
of 32
Search research articles
Search
Showing results (261-270 of 320) with videos related to
Sort By:
Page
of 32
The Journal of Infectious Diseases
|
May 1, 1984
Dose response of cold-adapted, reassortant influenza A/California/10/78 virus (H1N1) in adult volunteers
B R Murphy, M L Clements, H P Madore, et al.
Reviews of Infectious Diseases
|
May 1, 1989
Prospects for development of a rotavirus vaccine against rotavirus diarrhea in infants and young children
A Z Kapikian, J Flores, Y Hoshino, et al.
Blood
|
October 9, 2010
Distinct molecular mechanisms responsible for bortezomib-induced death of therapy-resistant versus -sensitive B-NHL cells
Scott H Olejniczak, Jennifer Blickwedehl, Alan Belicha-Villanueva, et al.
The Journal of Infectious Diseases
|
October 17, 2019
A Novel Antiparasitic Compound Kills Ring-Stage Plasmodium falciparum and Retains Activity Against Artemisinin-Resistant Parasites
Rebecca L Clements, Vincent Streva, Peter Dumoulin, et al.
Infection and Immunity
|
May 1, 1982
Evaluation of a phenotypic revertant of the A/Alaska/77-ts-1A2 reassortant virus in hamsters and in seronegative adult volunteers: further evidence that the temperature-sensitive phenotype is responsible for attenuation of ts-1A2 reassortant viruses
M D Tolpin, M L Clements, M M Levine, et al.
Journal of Clinical Gastroenterology
|
December 1, 1985
Percutaneous biopsy of pancreatic masses
V M Phillips, T Hersh, B C Erwin, et al.
Journal of Neuro-Oncology
|
September 22, 2018
KX2-361: a novel orally bioavailable small molecule dual Src/tubulin inhibitor that provides long term survival in a murine model of glioblastoma
Michael J Ciesielski, Yahao Bu, Stephan A Munich, et al.
The Journal of Infectious Diseases
|
March 1, 1993
Safety and immunogenicity of a recombinant protein influenza A vaccine in adult human volunteers and protective efficacy against wild-type H1N1 virus challenge
L F Fries, S B Dillon, J E Hildreth, et al.
The Journal of Infectious Diseases
|
August 11, 1992
Vaccination of vaccinia-naive adults with human immunodeficiency virus type 1 gp160 recombinant vaccinia virus in a blinded, controlled, randomized clinical trial. The AIDS Vaccine Clinical Trials Network
B S Graham, R B Belshe, M L Clements, et al.
International Immunology
|
June 6, 2000
In vitro and in vivo macrophage function can occur independently of SLP-76
P S Myung, J L Clements, D W White, et al.
Page
of 32